COURTESY DUNE MEDICAL DEVICES
health
Our Staff Regularly Works
with Residents from Meer and
other Independent and
Assisted Living Facilities
Private Duty Care to Fit Your Needs
)PVSMZt8FFLMZt$BSF
We are a family owned and operated and maintain
rigorous quality standards for all of our caregivers.
We make sure families feel comfortable with the
care and are informed on a regular basis.
| email: Duelsmann@BestPrivateDuty.com
www.BestPrivateDuty.com
2153370
Dedicated to the
academic and social
success of 6th-12th
grade students with
language-based
learning differences,
including autism,
anxiety disorders,
and attention
defi cits.
AIM HIGH SCHOOL
Grades
6-12
NOW ENROLLING
Dune Medical
Devices’ breast
cancer probe helps
make sure doctors
get cancer-free
margins.
t4NBMMDMBTTFTUBVHIUCZMJDFOTFEUFBDIFST
t1FSTPOBMJ[FEDVSSJDVMVNT TUSPOHBDBEFNJDT MJGF
TLJMMTBOEDPNNVOJDBUJPO
t"TBGF IBQQZFOWJSPONFOUXIFSFWBSJFEMFBSOJOH
TUZMFTBOECBDLHSPVOETBSFWBMVFE
(248) 702-6922
www.aimhighschool.com
MAKE
THE RIGHT
CHOICE.
Making the right
choice can sometimes
be hard. That’s why
we are here to help,
every step of the way.
SPECIALIZING IN:
Traumatic Brain Injuries, Spinal Cord Injuries,
Stroke and Cognitive Impairment, Orthopedic
Injuries, Muscle Disorders and Paralysis
Family Owned and Operated Since 1999
E9HD=E9FGJG>FGNA
+)*)-FGNAJG9<$FGNA$EA,0+//*,0%.*,%00((E9HD=E9FGJJ=@9:&;GE
52
February 23 • 2017
jn
2125290
“I think it is the biggest advancement
in breast cancer surgery in a generation.”
— Dr. Alice Police
continued from page 51
The product is being used by
more than 100 hospitals in the
U.S., including Mt. Sinai Hospital
in Manhattan, Einstein Medical
Center in Philadelphia and UC
Irvine Health in California, and
12 in Israel. It has been used com-
mercially on some 10,000 patients,
Aharonowitz said.
Use of each probe costs around
$1,000 in the U.S., which is sig-
nificantly lower than the outlay
incurred by insurers when a
patient needs to undergo addition-
al surgery, he said. A recent article
in the Wall Street Journal stated
that re-excisions for lumpectomy
procedures range in price from
$9,000 to $16,000.
“A conservative approach,” the
cost and some hesitancy regard-
ing the false positives the instru-
ment sometimes gives — requiring
surgeons to remove further tissue
from the patient even when patho-
logical results later show it was
clear — could be preventing more
widespread adoption of the gadget.
According to the U.S. nonprofit
Breastcancer.org, about one in
eight women will develop invasive
breast cancer over the course of
her lifetime. In 2017, some 255,180
new cases of invasive breast cancer
are expected to be diagnosed in
women in the U.S. About 40,610
women in the U.S. are expected
to die in 2017 from breast cancer,
though death rates have been
decreasing since 1989.
Dr. Alice Police, a breast cancer
surgeon at UC Irvine Health, does
about 300 surgeries a year and has
been a surgeon for about 26 years.
She participated in Dune’s U.S.
clinical trial.
“I think it is the biggest advance-
ment in breast cancer surgery in
a generation,” she said in a video
testimonial on the company’s
website. “When we have to tell a
patient they need a second surgery
because the margins aren’t clear
from the first surgery, it is just
devastating for the patient psycho-
logically.”
Using the probe at the time of
the surgery gives immediate reas-
surance to the surgeon and is “very
simple and easy to use,” Police
said. •